Boston, MA, United States of America

De-Kuan Chang

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Malden, MA (US) (2016 - 2017)
  • Boston, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of De-Kuan Chang

Introduction

De-Kuan Chang is a prominent inventor based in Boston, MA, known for his significant contributions to the field of biomedical research. He holds a total of six patents, showcasing his innovative approach to developing therapeutic solutions.

Latest Patents

One of his latest patents is focused on humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof. This invention provides humanized monoclonal antibodies, bi-specific antibodies, antibody conjugates, and fusion proteins that bind to the chemokine receptor CCR4. The antibody is derived from CCR4-IgG1 and recognizes the same epitope. It contains either an IgG4 or a stabilized IgG4 to improve binding efficiency and reduce in vivo Fab arm exchange. The binding of these antibodies to CCR4 inhibits ligand-mediated activities and is utilized to treat symptoms of cancer.

Career Highlights

Throughout his career, De-Kuan Chang has worked with esteemed institutions such as Dana-Farber Cancer Institute Inc. and Brigham and Women's Hospital, Inc. His work has significantly impacted cancer research and treatment methodologies.

Collaborations

De-Kuan Chang has collaborated with notable colleagues, including Wayne A. Marasco and Quan Zhu, further enhancing the scope and impact of his research.

Conclusion

De-Kuan Chang's innovative work in developing humanized antibodies represents a significant advancement in cancer treatment. His contributions continue to influence the biomedical field and offer hope for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…